A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.

NCT06158152 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT: AM3 + Probiotic
DIETARY_SUPPLEMENT: Placebo
DIETARY_SUPPLEMENT: AM3

Sponsor

Industrial Farmacéutica Cantabria, S.A.